Both tumor and stroma regions of primary tumors had higher expression of immune activation and checkpoint markers—including Tim-3, CD27 and 4-1BB—compared to metastases located in all tissues (Fig. 2D). The gene discussed is HAVCR2; the disease is neoplasm.